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Compression gloves for patients
with hand arthritis (C-GLOVES):
A feasibility study
Alison Hammond and Yeliz Prior
Abstract
Introduction: Compression gloves are frequently provided to patients with hand arthritis. Evidence for effectiveness is
limited. The aim of this study was to determine feasibility of recruitment, assessment and treatment procedures, in
preparation for a future compression glove trial.
Methods: A non-randomised feasibility study with out-patients with either undifferentiated inflammatory arthritis,
rheumatoid arthritis or hand osteoarthritis, with moderate to severe hand pain. All received IsotonerTM compression
gloves provided by rheumatology occupational therapists. The main outcomes were feasibility of recruitment, assess-
ment and treatment procedures, trial outcome selection and sample size calculation. Participants were assessed at
baseline and four weeks. Assessments included: numeric rating scales (0–10) of hand pain (on activity, at rest, at night)
and stiffness; hand joint swelling; finger flexion; and hand function (Grip Ability Test).
Results:Of 318 patients screened, 86/204 (42%) of inflammatory and 68/114 (60%) of hand osteoarthritis patients were
eligible. Of these, 41 (48%: age: 59.10 (SD 12.54) years) and 32 (47%: age: 60.75 (SD 8.64) years) respectively, consented.
All completed four-week follow-up. Assessment and treatment protocols were feasible. Hand pain on activity and at
night, stiffness, joint swelling, finger flexion and hand function improved: e.g. hand pain on activity: inflammatory arthritis
change¼0.95 (SD 2.26; p¼ 0.01); osteoarthritis 1.57 (SD 1.78; p¼ 0.001). Participants reported improved hand
pain, stiffness and hand function as main benefits.
Conclusion: Procedures tested were feasible. The most relevant primary outcome was hand pain on activity. Future
trials would need 161 participants (Inflammatory arthritis) and 151 (hand osteoarthritis).
Trial registration: Clinical Trials.Gov: NCT01874067
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Introduction
Compression gloves are provided to people with hand
arthritis, with persistent moderate to severe hand pain,
stiffness and/or swelling, in order to improve hand
symptoms and hand function.1–4 Gloves are usually
made of nylon and elastane. The amount of elastane,
combined with glove fit, affects the amount of pressure
applied. Gloves’ mechanism of action is thought to be
that applying pressure: reduces articular and peri-
articular swelling; and increases blood flow, so increas-
ing hand temperature.1–4
Rheumatology occupational therapists in the United
Kingdom National Health Service prescribe
compression gloves to about a third of their patient
caseload with: undifferentiated inflammatory arthritis,
rheumatoid arthritis or hand osteoarthritis.5
IsotonerTM gloves are the most common make provid-
ed (Figure 1). Gloves can be prescribed for day- and/or
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night-time wear. Concomitant hand therapy can
include hand exercises and joint protection education.5
A systematic review of compression glove rando-
mised controlled trials6 identified four with moderate
to high risk of bias.1,7–9 These tested closed finger
gloves (i.e. enclosing fingertips) worn at night for one
to four weeks in people with rheumatoid arthritis (n¼ 8
to 24). Trials were inconclusive about effects on hand
pain, stiffness, grip and pinch strength, finger range of
motion and dexterity. None evaluated open finger
gloves (i.e. fingertips exposed) or day-time wear regi-
mens, which reflect modern-day practice.5 There is a
need for trials to evaluate the effects of compression
gloves in hand arthritis.
The aim of this study was to determine the feasibility
of recruiting to, assessing and delivering a standardised
compression glove intervention for people with hand
arthritis, to assist planning future trials in inflammato-
ry arthritis (specifically undifferentiated inflammatory,
early and established rheumatoid arthritis); and in
hand osteoarthritis. The objectives were to: develop
standardised assessment and treatment protocols for
compression gloves; assess feasibility of recruitment,
assessment and treatment procedures and planned out-
come measures; investigate recruitment and attrition
rates; explore the effects of compression gloves on
hand symptoms and function; investigate participants’




We conducted a non-randomised, prospective feasibil-
ity study: in people with either inflammatory arthritis
or hand osteoarthritis. Favourable ethical opinion was
provided by the East Midlands-Northampton Research
Ethics Committee (13/EM/0253). The trial is registered
with Clinical Trials.Gov: NCT01874067. All partici-
pants provided informed written consent.
Recruitment opened on 1st September 2013 and
closed 31st May 2014, with data collection completed
by August 2014. The study design and procedures were
planned with participating therapists and patient
research partners (Supplementary File I).
Setting
The setting was 10 rheumatology occupational therapy
departments: in five NHS district general hospitals,
three teaching hospitals and two community health
care centres in the United Kingdom. Treatment was
provided by 14 rheumatology occupational therapists.
Participants
Trial participant inclusion criteria were: aged 18 years
or over; diagnosed with either: inflammatory arthritis
(specifically: undifferentiated inflammatory arthritis,
(i.e. with persistent hand synovitis which cannot be
classified as a specific rheumatological disorder) or
rheumatoid arthritis) diagnosed by a Rheumatology
Consultant, or hand osteoarthritis (affecting the fin-
gers/hand and not solely the carpometacarpal phalan-
geal joint) diagnosed by a General Practitioner,
Consultant or Advanced Therapy Practitioner.
As per therapists’ usual care pathway, patients
should be experiencing persistent moderate to severe
hand pain, stiffness and/or swelling causing at least
one of:
• difficulty using the hands during the day (for day
wear), if the patient’s main problems are proximal
interphalangeal joint and/or metacarpophalangeal
joint involvement (rather than solely wrist and/or
thumb involvement, for which wrist working and/
or thumb spica splints are applicable);
• disturbed sleep (for night wear);
• and limited ability to use the hands in the morning,
if symptoms and hand function are not readily
improved by using warm water or exercise (for
night wear).
Participants should: be willing to wear the compres-
sion gloves as recommended; have enough hand
Figure 1. IsotonerTM compression glove.
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function to be able to don and doff gloves (unless help
available); and understand English enough to complete
self-report measures and understand glove wear
instructions. Additionally, eligible participants should
be able to attend a glove review and assessment
appointment four-weeks later.
We excluded patients diagnosed with: other inflam-
matory forms of arthritis affecting the hands (e.g. pso-
riatic arthritis, gout, ankylosing spondylitis); severe:
hand neuropathies, Raynaud’s disease and/or hand cir-
culatory disturbances (as these could be exacerbated by
compression glove wear); severe hand deformities pre-
venting glove-fitting; other medical conditions which
could alter hand function between assessments (e.g.
neurological conditions); and any contraindications to
glove-wear (e.g. eczema, broken skin).
Additional exclusion criteria were: patients should
not have received intra-articular or intra-muscular ste-
roid injections or started/changed oral steroids or anti-
inflammatory non-steroidal drugs within the last four
weeks; or started/changed disease modifying anti-
rheumatic drugs or biologic drugs within the last
12weeks. This was because drug changes could be a
confounding factor affecting outcomes. However, par-
ticipants with undifferentiated inflammatory arthritis
or rheumatoid arthritis, if newly diagnosed and recent-
ly started their drug regimen, could have such changes,
which were recorded at baseline. We also excluded
those who had previously worn compression gloves
and required replacements. Participants were not
excluded who previously received any other type of
hand splint.
Recruitment procedures
Participants were recruited by therapists from amongst
their caseload. They approached those with inflamma-
tory arthritis or hand osteoarthritis and persistent hand
symptoms only. Participants were provided with a
study explanation and that they were consenting to
allow their anonymised hand assessment data to be
forwarded to the researchers. Participants would still
be provided with gloves, as per the usual care pathway,
if clinically appropriate. If interested, participants were
screened. If eligible, they were given a fuller study
explanation and participant information sheet to
ensure written informed consent was received.
Intervention
All participants were fitted with IsotonerTM open
finger gloves (Figure 1), following the agreed treatment
protocol as specified in the therapist manual
(Supplementary File II). IsotonerTM gloves are made
of nylon containing 20% elastane and apply 23 to
32mm Hg pressure, according to the manufacturer’s
information.10 This is the highest amount of pressure
applied amongst compression glove makes available.
Therapists determined if gloves were prescribed for
one or both hands, and to be worn day and/or night,
based on clinical need. All participants continued to
receive usual care.
Outcome measures
Prior to glove fitting, therapists completed the agreed
assessment protocol as specified in the therapist
manual (Supplementary File II). A study box was pro-
vided to each site containing the therapist manual,
hand assessment record forms, Jobskin tape measures,
15-centimetre ruler, Grip Ability Test and a stopwatch,
to ensure standardised equipment and procedures.
Outcomes were:
• pain: three 0 to10 numeric rating scales of no to
severe hand pain when performing moderate hand
activities (such as cooking, housework or garden-
ing), when resting and at night.
• stiffness: duration of early morning stiffness in
minutes; and a 0 to 10 numeric rating scale of no
to severe hand stiffness.
• self-reported hand condition status: a five-point
scale of very severe (1)/severe/moderate/good/very
good (5).
• swelling of each of the 2nd to 5th proximal interpha-
langeal joint and combined 2nd to 5th metacarpo-
phalangeal joints (except in HOA): using a single-use
Jobskin paper tape measure in centimetres.11
• composite finger flexion for each of the 2nd to 5th
digits measured using a 15-centimetre ruler.11,12
• Grip strength: using a Jamar dynamometer mea-
sured in kilograms.13 Only six sites owned a dyna-
mometer and, due to budget restrictions, we could
not provide these to the other four.
• Grip Ability Test: a timed test performing three
hand activities.14
• The Measure of Activity Performance Hand: a bilat-
eral self-report measure of performing 18 hand
activities (0 to 3 scale).15,16
At four-week follow-up, therapists again assessed
the above and recorded any drug regimen changes
and other hand therapy since glove fitting.
Participants reported if they discontinued glove wear
and why. Therapists asked participants: what effects, if
any, the gloves had; if they considered gloves beneficial,
what the most important benefit was; and any prob-
lems with wearing gloves. Therapists recorded key
points of responses (or verbatim if possible) on the
hand assessment record.
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Analysis
As this was a feasibility study, sample sizes were not
calculated. We aimed to recruit 40 participants with
inflammatory arthritis, and 40 with hand osteoarthritis,
as feasibility trial sample sizes are recommended as 20 to
40 participants.17,18 Results for the two patient groups
were reported separately. Recruitment and retention
rates were summarised descriptively. Analyses aimed
to determine if: future trials are feasible in inflammatory
arthritis or hand osteoarthritis and assist in outcome
selection, and not to evaluate effectiveness. For each
outcome, baseline and four-week follow-up data were
summarised using means and standard deviations, if
normally distributed, and tested using paired samples
t-tests, with effect sizes calculated using eta-squared:
t2/t2þ (n1). Guidelines for interpreting this are
0.01¼ small effect; 0.06¼moderate effect and
0.14¼ large effect.19,20 Ordinal or not normally distrib-
uted data was summarised using medians and inter-
quartile ranges and tested using Wilcoxon tests, with
effect sizes calculated as z/n and interpreted as
0.1¼ small effect; 0.3¼medium effect and 0.5¼ large
effect.19,20 Outcomes were analysed for dominant and
non-dominant hands. For pain outcomes, data were
also analysed per wear regimen, i.e. daytime pain on
activity and at rest were analysed for those recom-
mended to wear gloves in the daytime; and night pain
for those recommended to wear gloves at night.
Participants’ qualitative responses were content ana-
lysed, as responses were brief.21 Data were read, coded
and categorised by two researchers to ensure confirm-
ability. Frequencies and types of problems, positive
and negative effects and most important benefits were
reported.
Results
Recruitment and participant flow
Figure 2 shows recruitment and participant flow. Seven
sites opened as planned. However, three of these had
unexpected trouble purchasing gloves through their
NHS supply system, delaying recruitment by one to
four months. Research and Development department
approvals took longer than expected at the three other
sites: with one open for 7.5 and two for six months.
During the recruitment period, 42% of the inflamma-
tory arthritis and 60% of the hand osteoarthritis
patients screened were eligible. Of those eligible, 48%
and 47% respectively consented. Of those not consent-
ing, 32 (37% of those eligible) with inflammatory and
22 (32% of those eligible) with hand osteoarthritis were
either unable/unwilling to attend for the follow-up
appointment or the therapist was unable to provide
this to schedule (Figure 2). All participants received
gloves and no participants were lost to follow-up.
Participants
Demographic and clinical characteristics are shown in
Table 1. As the demographic characteristics and base-
line measures were similar between groups, apart from
symptom and diagnosis duration (Table 1).
Feasibility of recruitment, assessment and treatment
Per site, screening numbers varied between six and 61
patients. Recruitment rates also varied considerably:
between 0 and 16 participants per site, i.e. between 0
to 58% of those screened.
Four sites had two occupational therapists able to
treat and/or assess. However, it was usually not feasible
for them to act as independent assessor for the other’s
participants, due to workload constraints. Six sites
were unable to identify an independent assessor for
training, as the therapists were singe-handed
Rheumatology occupational therapists. Prior to the
study, at the training day (Supplementary File I), all
therapists demonstrated they could conduct the assess-
ments and fit compression gloves correctly. In both
groups, five participants were assessed after the
planned maximum five-week follow-up.
Glove wear and concomitant treatment
In both groups, most participants were issued gloves
for both hands (with almost all for their dominant
hand). Similar numbers were recommended day- and
night-time wear regimens, with about half recom-
mended a combined day and night wear regimen
(Table 1). A third (n¼ 14) with inflammatory arthritis
discontinued glove-wear either in the day- or night-
time, 10 of whom were prescribed gloves for both day
and night wear and continued wearing gloves part of
the time. Four with hand osteoarthritis also discontin-
ued glove wear part of the time. Reasons for discon-
tinuation are listed in Figure 2. By four-week follow-
up, 11 with inflammatory arthritis had drug regimen
changes (five disease modifying drugs; six steroid injec-
tions), no participants with hand osteoarthritis had
drug changes. Six people with inflammatory arthritis
received hand exercise and three joint protection edu-
cation; three with hand osteoarthritis received hand
exercise and joint protection education.
Outcomes
Outcomes are reported in Tables 2 and 3 for the dom-
inant hand only. At four-weeks, participants with
inflammatory arthritis or hand osteoarthritis both
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reported significantly less pain during moderate activ-
ities and at night (but not at rest during the day), as
well as less stiffness, with large effect sizes. In terms of
joint swelling, in the inflammatory arthritis group,
there were significant reductions in metacarpophalan-
geal joints and 3rd to 5th proximal interphalangeal
joints circumferences. These were small differences,
around 2mm or less, and it is unclear if these would
be clinically significant, even if statistically significant.
There were no significant changes in hand osteoarthri-
tis proximal interphalangeal joint circumferences.
Finger flexion improved significantly with moderate
Figure 2. Recruitment and participant flow in inflammatory arthritis (IA: includes undifferentiated inflammatory and rheumatoid
arthritis) and hand osteoarthritis (HOA) participants.
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to large effect sizes in some fingers in both the inflam-
matory arthritis and hand osteoarthritis groups. Hand
function improved significantly in both groups with
moderate effect sizes. Results were similar for non-
dominant hands (data not shown).
Participants’ views
Most participants reported benefits from wearing com-
pression gloves, although about a third also noted neg-
ative effects, reducing glove-wear as a result (Figure 2,
Table 4). The most common effects and important ben-
efits were reported as: hand symptom reduction (par-
ticularly pain); positive sensations from glove-wear
(particularly hands feeling supported or comforted);
and improved hand function (particularly activities
being easier) (Table 4). The benefits reported varied,
for example:
“They reduce stiffness. . . use them for short periods in
the morning. . .. pain relief using them after activities. . ..
can’t use them during household jobs as they
reduce grip. Beneficial if using a computer mouse. . ..
Gloves stop fingers bending up in the morning, Help
relax the hands and give comfort.” [53-year old
woman with RA].
“Eased the pain and stiffness...some reduction in swelling
(but might be due to the steroids)... easier to complete
things. . .comfortable and not restrictive.” [56-year old
woman with RA].
“Supportive, warming, they increase flexibility. . ..some
reduction in the time taken to ’get going’ in the
morning.” [48-year old woman with HOA].
“There’s no pain in the morning. It’s easier to move [my
hands] during the day. There’s no ’locking’ of my middle
fingers now.” [72-year old man with HOA].
Sample size
We used the hand pain on activity numeric rating scale
to calculate sample sizes needed for definitive superior-
ity randomised controlled trials of compression gloves












Age (years): mean (SD) 60.64 (15.34) 58.30 (11.05) 59.10 (12.54) 60.75 (8.64)
Gender (n) (men: women) 3:11 5:22 8:33 2:30
Symptom duration (years:
median, IQR)
0.75 (0.25–1.63) 8 (2-12) 3.58 (0.5–10) 4 (1.75–10)
Time since diagnosis (years:
median, IQR)
0.16 (0.08–0.33) 6 (2.33–11) 2.33 (0.23–8.5) 1.75 (0.19–8)
Current Medication (n):
-DMARDS 11 21 32 n/a
-oral steroids 3 3 6 n/a
-biologic drugs 0 5 5 n/a
-recent drug changes 5 – – –
Hand dominance (n) (right:
left)
13:1 24:3 37:4 28:4
Hand deformities (n):
dominant hand
4 11 17 2
Gloves fitted to (n):
Both; dominant only: non-domi-
nant only hands
10: 3: 1 23: 3: 1 33: 6: 2 25: 5: 2
















-day only 4 3 5 6 9 9 6 5
-night only 1 1 8 7 9 8 6 5
-day and night 6 7 13 11 21 18 18 17




UIA: undifferentiated inflammatory arthritis; RA: rheumatoid arthritis; DMARDS: disease modifying anti-rheumatic drugs; D: dominant hand; ND: non-
dominant hand.
Footnote: Inflammatory Arthritis group is the combined undifferentiated inflammatory arthritis and rheumatoid arthritis group.
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in inflammatory arthritis and in hand osteoarthritis.
The minimal clinically important difference for pain
in rheumatoid arthritis is 1.1 points on a 0 to 10
scale.22,23 There is no predefined minimal clinically
important difference for pain scales in hand osteoar-
thritis, but this was considered as a 0.5 standard devi-
ation of the mean baseline score.24 Baseline standard
deviations for hand pain on activity were 2.28 and 1.70
respectively. At a 5% significance level and 80%
power: for inflammatory arthritis, 67 participants
would be needed in each group, allowing for a 20%
drop-out rate, this would be 161 in total; in hand oste-
oarthritis, 63 would be needed in each group, with a
20% drop-out rate this would be 151 in total.25
Discussion
Most objectives of this feasibility study were met.
Standardised compression glove assessment and treat-
ment protocols were developed and could be success-
fully delivered by therapists. We achieved our
recruitment target of 40 participants with inflammato-
ry arthritis, but not for hand osteoarthritis. Outcomes
improved sufficiently to indicate definitive trials in
inflammatory arthritis and hand osteoarthritis are war-
ranted. This is a feasibility study and cannot identify if
gloves are effective. There were moderate to large effect
sizes in hand pain, stiffness and hand function (and
joint swelling in inflammatory arthritis). Reduced
hand pain was the most important glove-wear benefit
Table 2. Outcome measures at baseline and four weeks for the combined undifferentiated inflammatory and rheumatoid arthritis
group: Dominant hand (n¼ 39).












- during activitya 39 5.56 (2.28) 4.62 (2.31) 0.95 (2.26) 2.62 0.01 0.15
- at rest (day)a 39 4.10 (2.47) 3.67 (2.31) 0.44 (2.36) 1.15 0.26 0.03
- at nighta 39 4.41 (2.33) 3.44 (2.35) 0.97 (2.12) 2.87 0.01 0.18
Pain (0–10 NRS):
- during activityb 30 6.03 (1.73) 4.70 (2.34) 1.33 (2.19) 3.34 0.002 0.28
- at rest (day)b 30 4.60 (2.28) 3.80 (2.38) 0.80 (2.44) 1.79 0.08 0.10
- at nightc 30 3.90 (2.22) 2.87 (2.26) 1.03 (2.06) 2.75 0.01 0.21
Stiffness (0–10 NRS) 39 5.49 (2.62) 3.97 (2.33) 1.57 (2.27) 4.16 0.001 0.31
Joint circumference (cm.)
- 2nd PIPJ 38 6.67 (0.59) 6.60 (0.57) 0.07 (0.23) 1.91 0.06 0.09
- 3rd PIPJ 38 6.74 (0.59) 6.66 (0.55) 0.09 (0.23) 2.54 0.02 0.15
- 4th PIPJ 38 6.25 (0.56) 6.16 (0.53) 0.09 (0.20) 2.87 0.01 0.18
- 5th PIPJ 32 5.66 (0.61) 5.43 (0.57) 0.22 (0.41) 3.08 0.004 0.23
- 2nd to 5th MCPJs 38 19.87 (1.69) 19.70 (1.66) 0.17 (0.41) 2.54 0.02 0.15
Finger flexion (cm.)
- 2nd digit 38 6.33 (1.58) 6.10 (1.51) 0.22 (1.12) 1.23 0.23 0.05
- 3rd digit 37 5.48 (1.63) 4.93 (1.44) 0.55 (1.10) 3.12 0.004 0.21
- 4th digit 38 4.47 (1.51) 4.07 (1.26) 0.40 (1.16) 2.11 0.04 0.10
- 5th digit 38 4.47 (1.60) 4.04 (1.30) 0.43 (1.26) 2.14 0.04 0.11
Grip Ability Test (max.score 180) 37 43.11 (32.20) 37.47 (29.41) 5.64 (23.13) 1.48 0.15 0.06
Grip strength (kg.) 12 10.56 (8.58) 13.67 (6.93) 3.11 (5.46) 1.98 0.07 0.26
z and p values
Median (IQR) Median (IQR) z p
Perceived Hand severity (1–5) 38 2.5 (2–3) 3 (3–3) 3.38 0.001 0.55
MAP-HAND (bilateral:0-54) 41 21 (16–28) 20 (15–23) 2.14 0.03 0.33
Hand early morning stiffness
(bilateral; minutes)
38 60 (30–152.5) 35 (15–60) 3.98 <0.01 0.64
MAP-HAND: Measure of Activity Performance Hand; NRS: numeric rating scale; MCPJ: metacarpophalangeal joints; PIPJ: proximal interphalangeal
joint; IQR: inter-quartile range; SD: standard deviation;a all participants prescribed a glove for their dominant hand;b participants prescribed gloves for
daytime wear on dominant hand;c participants prescribed gloves for night-time wear on dominant hand.
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reported by participants. Effects were seen in both day-
time hand pain on activity and night-time pain. We
therefore selected the former as a primary outcome
for future trials, as participants more often reported
hand function benefits than sleep improvement.
Sample sizes were then estimated. Although we identi-
fied recruitment, assessment and treatment procedures
were feasible, we identified several issues in relation to
conducting a future trial.
Recruitment was problematic. There were delays in
starting recruitment, and numbers screened and con-
sented were lower than anticipated, particularly in
hand osteoarthritis. Delayed recruitment occurred at
three sites due to difficulties purchasing compression
gloves, which are normally provided as part of usual
care. In future trials, providing compression gloves to
sites would avoid this delay. Therapists could recruit
from amongst their caseloads but numbers screened
and recruited varied considerably between sites.
Average recruitment was five inflammatory and four
hand osteoarthritis participants/month. At this rate,
with these 10 sites, achieving the proposed sample
size in inflammatory arthritis would take 32-months
and 38-months in hand osteoarthritis. To recruit
within a feasible time frame, e.g. around 16 to
18months within a typical three-year trial, will require
more sites and increasing screening and consenting
rates at each.
Increasing screening rates is feasible in inflammato-
ry arthritis. Patients are referred to occupational ther-
apy from rheumatology out-patient clinics. There are
likely to be more patients with moderate to severe hand
pain attending clinics but not being referred.
Expanding recruitment into rheumatology out-patient
Table 3. Outcome measures at baseline and four weeks for the hand osteoarthritis group: Dominant hand (n¼ 30).












- during activitya 30 7.27 (1.70) 5.70 (2.34) 1.57 (1.78) 4.83 0.001 0.44
- at rest (day)a 30 4.70 (2.18) 4.07 (1.99) 0.63 (1.88) 1.84 0.08 0.10
- at nighta 30 6.13 (2.43) 3.90 (2.50) 2.33 (2.62) 4.67 0.001 0.43
Pain (0–10 NRS):
- during activityb 24 7.38 (1.81) 5.79 (2.21) 1.58 (1.74) 4.45 0.001 0.46
- at rest (day)b 24 4.92 (2.15) 4.29 (2.01) 0.63 (2.02) 1.52 0.14 0.09
- at nightc 24 5.63 (2.45) 3.46 (2.28) 2.17 (2.60) 4.08 0.001 0.42
Stiffness (0–10 NRS) 30 7.00 (1.60) 5.53 (2.37) 1.47 (2.45) 3.29 0.003 0.27
Joint circumference (cm.)
- 2nd PIPJ 30 6.57 (0.45) 6.51 (0.52) 0.06 (0.19) 1.82 0.08 0.10
- 3rd PIPJ 30 6.62 (0.51) 6.63 (0.91) 0.01 (0.25) 0.22 0.83 <0.01
- 4th PIPJ 30 6.30 (0.93) 6.23 (0.55) 0.08 (0.22) 1.88 0.07 0.11
- 5th PIPJ 30 5.34 (0.56) 5.39 (0.42) 0.01 (0.45) 0.08 0.94 <0.01
Grip strength (kg.) 11 13.06 (8.85) 15.18 (10.21) 2.12 (4.76) 1.48 0.17 0.17
z and p values
Median (IQR) Median (IQR) z p
Finger flexion (cm..)
- 2nd digit 30 6.80 (5.06–7.65) 5.65 (5.15–7.03) 2.34 0.02 0.43
- 3rd digit 30 5.15 (4.38–6.60) 4.50 (3.88–5.53) 2.08 0.04 0.38
- 4th digit 30 4.75 (3.38–6.30) 3.50 (3.23–5.73) 2.29 0.02 0.42
- 5th digit 30 4.20 (3.25–5.35) 3.65 (3.08–5.00) 1.22 0.22 0.06
Grip Ability Test
(max. score 180)
30 35.71 (29.02–48.04) 30.08 (26.08–40.09) 2.89 0.004 0.53
Perceived Hand severity (1–5) 28 2 (2–3) 3 (2–3) 2.52 0.01 0.31
MAP-HAND (bilateral:0-54) 32 24.50 (18.50–32.50) 23.50 (16.50–26.75) 1.77 0.08 0.31
Early morning stiffness (minutes) 31 60 (30–120) 60 (15–90) 0.71 0.48 0.13
MAP-HAND: Measure of Activity Performance Hand; NRS: numeric rating scale; PIPJ: proximal interphalangeal joint; IQR: inter-quartile range; SD:
standard deviation;a all participants prescribed a glove for their dominant hand;b participants prescribed gloves for daytime wear on dominant hand;c
participants prescribed gloves for night-time wear on dominant hand.
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clinics should increase numbers screened. Fewer hand
osteoarthritis patients were screened, meaning trial
recruitment could be more problematic. Referrals typ-
ically come from General Practitioners. However,
many with hand osteoarthritis may not seek help,
even when in severe pain, feeling that nothing can be
done.26 Only 3% of those with severe hand osteoarthri-
tis reported being referred to an occupational therapist
within the last year.27 A trial in hand osteoarthritis
would therefore require identifying sites receiving
high numbers of primary care referrals and/or with
effective primary care research recruitment pathways.
Increasing consenting rates is also required. Of those
screened, 16% with inflammatory arthritis, and 19% of
those with hand osteoarthritis, were eligible but unable
to attend for the four-week follow-up glove review and
assessment or the therapist was unable to provide a
suitably timed appointment (e.g. due to annual leave),
meaning these patients could not be recruited.
Conducting telephone glove reviews and collecting
data via mailed self-report questionnaires would
avoid the need for this second visit, as well as reducing
participant burden. Remote reviews also normally
occur in usual care and are therefore a feasible
alternative.5
Whilst therapists were able to conduct hand assess-
ments, including the objective outcomes (i.e. finger
flexion, joint circumferences, Grip Ability Test and
grip strength), it was not feasible to have independent
assessors, as other staff within participating depart-
ments did not have sufficient time or availability to
conduct assessments to schedule. Future trials would
therefore need to fund independent assessors, increas-
ing trial costs considerably, and ensure they are avail-
able to meet the assessment schedule. Logistically, this
is likely to prove difficult. If a trial is portfolio adopted
by the UK Clinical Research Networks, NHS research
facilitators (i.e. usually research nurses or clinical trials
assistants) also can conduct assessments in trials, as
well as recruiting.28 However, in practice it can be dif-
ficult to get the additional and sustained commitment
to conduct assessments within rehabilitation trials.
Table 4. Frequency of self-reported compression glove effects and most important benefits from glove-wear.
Perceived effects of
compression gloves (n)
Most important benefit of
compression gloves (n)
Category and code IA (n¼ 41) HOA (n¼ 32) IA (n¼ 35) HOA (n¼ 30)
Positive effects: 35 30
Type of positive effects:
1 Hand symptom reduction: 21 22 – –
- pain/aching 15 16 14 7
- stiffness 9 11 3 5
- swelling 7 5 0 2
- pins and needles/numbness 0 3 0 0
2 Positive hand sensations 19 16 – –
- supportive 11 11 8 4
- comforting/comfortable 9 7 2 2
- warmth 4 3 0 1
3 Improved hand movement and function: 12 10 – –
- activities easier 7 7 1 5
- fingers more flexible 6 4 3 2
- grip stronger 3 0 3 0
- fingers less curled in the morning 3 2 0 0
4 Improved sleep 2 3 1 2
No effects 6 2 – –
Negative effects: 12 10 – –
- itching/ irritating/ too hot 4 4 – –
- increased aches/pain 4 4
- limiting hand function/ finger flexion 3 1 – –
- get dirty/scruffy quickly 2 1
- increased stiffness 0 2 – –
- pressure making finger nodes sore 0 1 – –
- uncomfortable 1 0 – –
- problem taking on/off for toilet at night 0 1
IA: inflammatory arthritis; HOA: hand osteoarthritis. Participants could experience both of and more than one positive or negative effect in each
category.
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Participants reported the main benefits were improved
hand pain, stiffness and hand function. As these can be
validly and reliably collected using patient reported
outcome measures, we recommend self-report ques-
tionnaires are used for data collection in future trials,
in order to contain trial costs.
The results should not be considered as indicating
compression gloves improve hand symptoms and func-
tion, as participants were not randomised to a control
group nor were there independent assessors. A quarter
of inflammatory arthritis participants had steroid injec-
tions or drug changes during the trial, which could
contribute to improvements. Only a randomised con-
trolled trial with independent or self-report outcome
assessment can answer if compression gloves are
effective.
The strengths of this study were that we developed
the recruitment, assessment and treatment procedures
through expert consensus with therapists from the 10
participating sites and patient research partners to
ensure these were feasible in clinical practice and
acceptable to patients. This means that protocols
were likely to be acceptable in a future trial. We
ensured therapists were able to: provide and fit gloves
correctly, through observation and feedback from
researchers and patient research partners; and conduct
assessments correctly through a reliability study of
objective measures. Best usual care practice was
agreed across sites. We assessed open finger Isotoner
TM compression gloves, which are the most common
gloves used in clinical practice5 and have not previously
been evaluated.6 Participants comments provided
insights into perceived benefits of glove wear, influenc-
ing planning for future trial outcome choices and data
collection methods. This was also the first study explor-
ing effects of daytime compression glove-wear and in
hand osteoarthritis.
The limitations were that there was no control group
and therefore we do not know if participants would
accept randomisation to a control group. Further con-
sensus is required with clinical therapists and patient
research partners as to what should constitute a control
group: e.g. receiving either hand exercise and joint pro-
tection education as “usual care”; an attention-control
intervention of similar duration; or placebo gloves. If
placebo gloves are used, then a suitable placebo glove
needs identifying. For example, previous studies have
used: loose-fitting compression gloves;7 non-stretch
cotton gloves8 or thermal gloves.1 We also do not
know if therapists would be willing to recruit into a
randomised controlled trial. Therapists provide gloves
to about a third of their caseload. It will therefore be
essential when recruiting therapists, and during train-
ing, to discuss the very limited evidence for compres-
sion glove effectiveness. For example, if the control
group receives placebo gloves, therapists will need to
be willing to accept that there is clinical equipoise
between compression and placebo gloves. Therapists
will therefore need to consider their current beliefs
about glove effectiveness in order to be willing to
recruit and accept randomisation. Additionally, they
would need training in how to deliver placebo gloves
convincingly.29 Further work with patient research
partners is needed to discuss how best to describe to
patients the current lack of evidence for compression
gloves, and the need for a trial to test these, in order for
patients to be willing to be randomised into a trial. We
did not have independent assessors or interviewers,
which could have introduced bias.
In a future trial, provision of concomitant hand
therapy should be standardised, as participants had
varying amounts of this. Participants’ perceptions of
compression gloves highlighted adverse effects and
why some stopped wearing these as recommended. In
a future trial, self-reported glove-wear and in-depth
interviews by an independent interviewer would pro-
vide better insights into participants’ use of and percep-
tions of compression gloves. Further assessment of
treatment fidelity is also recommended, e.g. through
observation of treatment sessions, which may now be
more feasible remotely with increased access to video
meeting facilities. There was a high level of adverse
events. This led to some stopping glove wear and
others reducing glove wear during the day or night.
In a future trial, the effects of glove provision (as
opposed to glove wear) need to be tested, as this reflects
the reality of clinical practice. An intent-to-treat anal-
ysis should therefore be conducted, with a per protocol
analysis excluding those not receiving gloves for any
reason.
In conclusion, a trial of compression gloves is war-
ranted and procedures are feasible in inflammatory
arthritis. This study identified issues to be addressed.
It also provides an example of how expert clinical ther-
apist and patient research partners consensus can be
obtained to develop trial and treatment protocols, in
both research and for clinical practice. A mixed method
randomised controlled trial, with a nested qualitative
study and independent interviewer, was planned at 16
sites in the United Kingdom, additionally recruiting
from rheumatology clinics.30 The trial includes stand-
ardised concomitant hand therapy, telephone or in-
person glove review, and data collection with mailed
self-report questionnaires. Outcomes are hand pain on
activity and at night, hand stiffness, hand function and
an economic analysis comparing the costs and health
benefits of compression gloves from a health and social
care perspective. A future trial in hand osteoarthritis is
warranted but requires a clear primary care and
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community recruitment pathway to ensure enough
recruitment.
Online supplementary file I: C-Gloves Phase 1 fea-
sibility study planning
Online supplementary file II: C-GLOVES: Therapist
Compression Glove Hand Assessment and Treatment
Manual.
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